Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 29% ± 6% | |
lung | 11 studies | 27% ± 7% | |
intestine | 8 studies | 21% ± 9% | |
liver | 5 studies | 26% ± 18% | |
pancreas | 4 studies | 37% ± 14% | |
lymph node | 4 studies | 32% ± 10% | |
brain | 4 studies | 33% ± 4% | |
kidney | 3 studies | 26% ± 8% | |
placenta | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6158.05 | 1445 / 1445 | 100% | 163.09 | 183 / 183 |
liver | 100% | 6860.42 | 226 / 226 | 100% | 189.36 | 406 / 406 |
ovary | 100% | 6053.90 | 180 / 180 | 100% | 217.27 | 430 / 430 |
pancreas | 100% | 6562.23 | 328 / 328 | 100% | 199.72 | 178 / 178 |
skin | 100% | 5923.50 | 1809 / 1809 | 100% | 255.27 | 472 / 472 |
thymus | 100% | 7963.62 | 653 / 653 | 100% | 157.41 | 605 / 605 |
uterus | 100% | 6964.12 | 170 / 170 | 100% | 244.88 | 459 / 459 |
lung | 100% | 7223.96 | 578 / 578 | 100% | 220.23 | 1153 / 1155 |
stomach | 100% | 6562.76 | 359 / 359 | 100% | 193.86 | 285 / 286 |
brain | 100% | 4015.18 | 2632 / 2642 | 100% | 174.32 | 705 / 705 |
intestine | 100% | 7197.36 | 966 / 966 | 100% | 220.89 | 525 / 527 |
bladder | 100% | 6650.29 | 21 / 21 | 100% | 259.61 | 502 / 504 |
prostate | 100% | 7807.66 | 245 / 245 | 100% | 187.79 | 500 / 502 |
adrenal gland | 100% | 6301.04 | 258 / 258 | 100% | 137.62 | 229 / 230 |
kidney | 100% | 6094.36 | 89 / 89 | 100% | 145.52 | 897 / 901 |
breast | 100% | 6341.68 | 459 / 459 | 100% | 192.16 | 1113 / 1118 |
adipose | 100% | 6475.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 230.97 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 219.68 | 29 / 29 |
spleen | 100% | 10384.70 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 179.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 182.57 | 1 / 1 |
heart | 100% | 3892.71 | 860 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 4933.98 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5373.13 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5507.76 | 920 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009615 | Biological process | response to virus |
GO_0140042 | Biological process | lipid droplet formation |
GO_1990044 | Biological process | protein localization to lipid droplet |
GO_0030970 | Biological process | retrograde protein transport, ER to cytosol |
GO_0061724 | Biological process | lipophagy |
GO_0034389 | Biological process | lipid droplet organization |
GO_0036503 | Biological process | ERAD pathway |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005776 | Cellular component | autophagosome |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0005515 | Molecular function | protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
Gene name | AUP1 |
Protein name | Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1) |
Synonyms | |
Description | FUNCTION: Plays a role in the translocation of terminally misfolded proteins from the endoplasmic reticulum lumen to the cytoplasm and their degradation by the proteasome . Plays a role in lipid droplet formation . Induces lipid droplet clustering . Recruits ubiquitin-conjugating enzyme UBE2G2 to lipid droplets which facilitates its interaction with ubiquitin ligases AMFR/gp78 and RNF139/TRC8, leading to sterol-induced ubiquitination of HMGCR and its subsequent proteasomal degradation . Also required for the degradation of INSIG1, SREBF1 and SREBF2 . Plays a role in regulating assembly and secretion of very low density lipoprotein particles and stability of apolipoprotein APOB . .; FUNCTION: (Microbial infection) Following Dengue virus infection, required for induction of lipophagy which facilitates production of virus progeny particles. . |
Accessions | Q9Y679 ENST00000377526.4 [Q9Y679-2] ENST00000425118.5 [Q9Y679-3] |